MA
TMDX icon

MCF Advisors’s Transmedics TMDX Stock Holding History

MCF Advisors’s Portfolio TMDX Stock Details TMDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$13.6K Hold
137
– – ﹤0.01% 900
2025
Q4 		$16.7K Buy
137
+75
+121% +$9.41K ﹤0.01% 728
2025
Q3 		$6.96K Sell
62
-78
-56% -$9.13K ﹤0.01% 753
2025
Q2 		$18.8K Buy
+140
New +$15.4K ﹤0.01% 561
2024
Q4 		– Sell
-291
Closed -$45.7K – 1046
2024
Q3 		$45.7K Sell
291
-76
-21% -$11.7K ﹤0.01% 411
2024
Q2 		$55.3K Sell
367
-190
-34% -$22.8K ﹤0.01% 366
2024
Q1 		$41.2K Hold
557
– – ﹤0.01% 411
2023
Q4 		$44K Sell
557
-29
-5% -$1.75K ﹤0.01% 388
2023
Q3 		$32.1K Buy
586
+37
+7% +$2.66K ﹤0.01% 416
2023
Q2 		$46.1K Sell
549
-62
-10% -$4.75K ﹤0.01% 371
2023
Q1 		$46.3K Sell
611
-184
-23% -$12.7K ﹤0.01% 365
2022
Q4 		$49.1K Sell
795
-247
-24% -$13.1K 0.01% 345
2022
Q3 		$43K Buy
+1,042
New +$45.3K ﹤0.01% 354

Other funds holding TMDX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return
NAMI
Nomura Asset Management International Philadelphia, Pennsylvania $58.4B AUM
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

MCF Advisors's TMDX Position: Q1 2026 in Review

MCF Advisors held its Transmedics (TMDX) position steady in Q1 2026 at 137 shares worth $13.6K. The position accounts for ﹤0.01% of the portfolio, ranked #900.

MCF Advisors first reported a position in TMDX in Q3 2022 and has held it in 13 quarters since. The position peaked at $55.3K in Q2 2024. 414 funds tracked by Wall St. Rank hold TMDX as of Q1 2026.

  • MCF Advisors held 137 shares of Transmedics worth $13.6K as of Q1 2026.
  • MCF Advisors left its Transmedics share count unchanged in Q1 2026.
  • Transmedics made up ﹤0.01% of MCF Advisors's portfolio in Q1 2026, its #900 holding.
  • MCF Advisors first reported a position in Transmedics in Q3 2022 and has held it in 13 quarters since.
  • MCF Advisors's Transmedics position peaked at $55.3K in Q2 2024.
  • 414 funds tracked by Wall St. Rank held Transmedics as of Q1 2026.

Based on MCF Advisors's 13F filing for Q1 2026, filed 11 May 2026.